The absolute eosinophil count (AEC) on a routine complete blood count could be a useful addition when deciding which patients to work up for RA-ILD.
Article
Dr. John Cush
Tweet
Beyond HLA-B27: Anti-14-3-3eta Autoantibodies as a Candidate Marker in axSpA
14-3-3 proteins are a conserved family of seven isoforms with diverse cellular functions, found predominantly intracellularly. The 14-3-3eta isoform has been studied as a proinflammatory mediator in RA https://t.co/tErmfDBy1r
Dr. John Cush
Tweet
Pre-RA: Antibodies Sort the Risk, Ultrasound Erosions Flag Severity
Three ACR 2026 abstracts from the Leeds CCP cohort tested how to triage anti-CCP positive individuals with musculoskeletal symptoms. Serology and a few clinical items carried the prediction, while ultrasound https://t.co/91HG7xPS3o
Dr. John Cush
Tweet
“Age old” biomarkers in ILD and pulmonary fibrosis
At #ACR26, there was a poster on senescence being increased in SARD-ILD (systemic autoimmune rheumatic disease – interstitial lung disease) including fibrotic (progressive pulmonary fibrosis), showing epithelial remodeling from https://t.co/cNxgqJIH8T
Dr. John Cush
Tweet
Beyond HLA-B27: Anti-14-3-3eta Autoantibodies as a Candidate Marker in axSpA
14-3-3 proteins are a conserved family of seven isoforms with diverse cellular functions, found predominantly intracellularly. The 14-3-3eta isoform has been studied as a proinflammatory mediator in RA https://t.co/yC4bhtnTCD
Antoni Chan MD (Prof)
Tweet
ACR26 summary, AI and documentation: errors on all five AI platforms tested against guidelines, and cDAPSA documented in 4.9% of PsA records @rheumnow #ACR26 Abstract#0869 Abstract#1348
Akhil Sood MD, MS
Tweet
Erosions and seronegative RA?
Abstract 2932 found anti-MFN1
- IgG a/w with inc risk of radiographic erosions at baseline (OR 3.04) & 2 years (OR 3.24) + the adjusted model
- IgA a/w erosive disease at baseline only; higher erosion score at baseline & 2 years
@RheumNow #ACR26
Daric Mueller, PA-C
Tweet
(1/2)#ACRBest Dazodalibep (DAZ) for systemically active SjD Ph3 top line results! LB22
648 pts
IV DAZ 1500mg Q4W or 3000mg Q12W vs placebo
Signf improved ESSDAI in both DAZ arms @ 48W. ESDAI differences vs placebo -1.8 for 1500mg Q4W, -1.4 for 3000mg Q12W
@RheumNow #ACR26
Mrinalini Dey
Tweet
In 60 RA patients, grayscale ultrasound correlated with biopsy inflammation in early and refractory disease. Power Doppler correlated only in early RA. Biopsies with high ultrasound scores but little inflammation often showed scar tissue. #2934 @Rheumnow #ACR26
Mrinalini Dey
Tweet
Higher orosomucoid-1 levels were associated with future difficult-to-treat RA in two cohorts (n=198). Samples were taken years before D2T criteria were met. Independent validation using ELISA showed an AUC of 0.86. #2933 @Rheumnow #ACR26
Dr. John Cush
Tweet
Eosinophilia and RA-ILD
The absolute eosinophil count (AEC) on a routine complete blood count could be a useful addition when deciding which patients to work up for RA-ILD.
https://t.co/MxJTYJCcVk https://t.co/uHP2FwdAmi
Mrinalini Dey
Tweet
Anti-mitofusin-1 IgG was found in 9.7% of 638 ESPOIR patients with early arthritis. In RF/ACPA-negative patients, positivity was linked to higher odds of erosions at 2 years (aOR 3.47; 95% CI 1.17-11.0). A potential marker of erosive seronegative RA. #2932 @Rheumnow #ACR26
sheila
Tweet
Biomarker data on Ph2 Affinity Study (Gus+Gol vs Gus) in PsA
Combi Gus+Gol and mono Gus significantly reduced sIL-17A/F & BD2 levels
Gus+Gol decr CRP, IL-6 & TNG activity thru wk 24
@RheumNow #ACR26 Abs2943 https://t.co/n1dxn0EREy
Richard Conway
Tweet
Noaiseh et al. Phase 3 OASIZ-301 RCT. Dazodalibep in Sjogens. Positive study. Effect by week 4. Secondary outcomes on sicca also met. Similar adverse events to placebo. @RheumNow #ACR26 Abstr#LB22 https://t.co/s4E44IMpS8
Jiha Lee
Tweet
LB21: TARA - Phase 3, DB, active-controlled RCT
Girocitinib (TLL-018) - highly selective JAK1/TYK2 dual inhibitor - vs JAKi in active RA refractory to bDMARDs
ACR50 at 24wks: 73.0% versus 49.5%
Potential option for D2T RA?!
#ACR26 @RheumNow https://t.co/SGkZjP994P
Janet Pope
Tweet
#unmet need for #urate #lowering in #gout w #URAT1i #pozdeutinurad Tophi 1/4 >8 baseline uric acid (American units) Sustained uric acid over time Benefit from 6mo onward Rare EAs /SAEs DBRCT 2 doses, 75&150mg works Some failed other prior Rx #ACR26 #ACRbest @RheumNow #LB20 https://t.co/83aCtazXwt
sheila
Tweet
Ph 2A study on OSCA for knee OA showed single inj was well tolerated w/ sustained relief at 6 mos
Decr sIL-1B, sCOMp, uCTX-II at mo 6.
@RheumNow #ACR26 LB19 https://t.co/22jWTu8DCu
Adela Castro
Tweet
Lip biopsy for Sjogren's disease diagnosis?
Great debate at #ACR26 @RheumNow
Bella Mehta
Tweet
We used a pathology foundation model to identify interpretable spatial “microniches” in RA synovial histology #ACR26 abst#1087. It reproduced established pathologic features and identified lymphocytic inflammation associated with ESR, tissue based precision rheumatology @RheumNow https://t.co/pJRnbczgWC
Mrinalini Dey
Tweet
Do we have a marker for RA-ILD severity? Higher MMP7 was assoc with greater CT involvement and lower DLCO; not FVC or respiratory symptom scores.
HRCT & DLCO also more sensitive indicators of RAILD progression and severity than FVC and respiratory PROs #2886 @Rheumnow #ACR26
Richard Conway
Tweet
Anthone et al. MMP-7 associated with greater chest CT involvement and lower DLCO in multicenter, prospective RA-ILD cohort. ?utility as biomarker of RA-ILD severity. @RheumNow #ACR26 Abstr#2886 https://t.co/32kggO6VEF
Richard Conway
Tweet
Wheeler et al. VARA-ILD CRS v2.0 for RA-ILD. Performs better than MUC5B+-clinical factors alone @RheumNow #ACR26 Abstr#2885 https://t.co/3WThltnQmq
Janet Pope
Tweet
NO small feat!
A nanoparticle target of
Myeloid inhibiting #JAK in #RA
Some JAK #dendranib candidates have been found and are being studied
Cool technology- need to follow this space
#2028 #ACR26 @ACRheum @RheumNow https://t.co/X9E5LzyY0h
Daric Mueller, PA-C
Tweet
RTX for joint manifestations of SSc?
Abs 2158 Study of 80 SSc pts from Uni of Lübeck with documented DAS-CRP treated with RTX suggesting improvement and possible remission by this measure. Concomitant MMF one feature that favored remission? Small, uncontrolled
#ACR26 @RheumNow https://t.co/vphSxCfeBJ
Mike Putman
Tweet
Interesting abstract re:clonal hematopoiesis of ), age-related mutations in peripheral blood DNA
CHIP was more common among pts w/GCA after correctingf or age and sex (OR 1.51). SRSF2 associated w/large vessel disease; TET2 associated w/cranial phenotype
Not ready for clinic, https://t.co/ZEZiob0HWU
